The latest monthly scorecard for the signals generated from Rocket Tickers can be downloaded here. The results are summarized in this table: May Scorecard Number of Signals 6 Percent Correct – Prev Close to 5-day Peak 83% Avg Increase – Next open to 5-day Peak 7% Other stats: Number of signals over $10/share 3 Number […]
On June 6, La Jolla Pharmaceutical Company (LJPC) announced positive clinical trial results from its Phase 2 study of LJPC-401. This was a pre-specified interim analysis of its synthetic human hepcidin in patients with hereditary hemochromatosis (HH). Patients experienced statistically significant efficacy levels and tolerated the drug well. Rocket Tickers detected the news event […]
The latest monthly scorecard for the signals generated from Rocket Tickers can be downloaded here. The results are summarized in this table: April Scorecard Number of Signals 4 Percent Correct – Prev Close to 5-day Peak 100% Avg Increase – Next open to 5-day Peak 100% Other stats: Number of signals over $10/share 2 Number […]
The latest monthly scorecard for the signals generated from Rocket Tickers can be downloaded here. The results are summarized in this table: January Scorecard Number of Signals 15 Percent Correct – Prev Close to 5-day Peak 100% Avg Increase – Next open to 5-day Peak 10% Other stats: Number of signals over $10/share 8 Number […]
On March 27, Lannett Company, Inc. (LCI) reported that they have received FDA approval for their Abbreviated New Drug Application (ANDA) for Aspirin and Extended-Release Dipyridamole Capsules, 25mg/200mg. The drug is the therapeutic equivalent to Aggrenox Capsules, 25 mg/200 mg by Boehringer Ingelheim Pharmaceuticals. Total annual sales in the US for Aspirin and Extended-Release Dipyridamole […]
The latest monthly scorecard for the signals generated from Rocket Tickers can be downloaded here. The results are summarized in this table: January Scorecard Number of Signals 11 Percent Correct – Prev Close to 5-day Peak 100% Avg Increase – Next open to 5-day Peak 6% Other stats: Number of signals over $10/share 9 Number […]
On February 19, Allakos, Inc. (ALLK) announced positive Phase 1 clinical trial results for its drug AK002, which is used to treat eosinophil and mast cell related diseases. The drug is being tested on patients with indolent systemic mastocytosis (ISM), a debilitating disorder caused by the release of inflammatory mediators from mast cells, who had […]
The latest monthly scorecard for the signals generated from Rocket Tickers can be downloaded here. The results are summarized in this table: January Scorecard Number of Signals 10 Percent Correct – Prev Close to 5-day Peak 90% Avg Increase – Next open to 5-day Peak 8% Other stats: Number of signals over $10/share 6 Number […]
The latest monthly scorecard for the signals generated from Rocket Tickers can be downloaded here. The results are summarized in this table: December Scorecard Number of Signals 12 Percent Correct – Prev Close to 5-day Peak 75% Avg Increase – Next open to 5-day Peak 7% Other stats: Number of signals over $10/share 12 Number […]
The latest monthly scorecard for the signals generated from Rocket Tickers can be downloaded here. The results are summarized in this table: November Scorecard Number of Signals 8 Percent Correct – Prev Close to 5-day Peak 88% Avg Increase – Next open to 5-day Peak 8% Other stats: Number of signals over $10/share 5 Number […]
Simply register below to get sample signals as they come out!
